Fact CheckerSign in

NCT06555237RecruitingPhase 2

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (MEKinRAS) - Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 15 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this study is to evaluate the effectiveness of trametinib treatment in patients with Hyperthropic cardiomyopathy and a genetic mutation in the RAS/MAPK pathway.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
First submitted
12 Aug 2024
Start date
1 Aug 2024
Primary completion date
1 Aug 2026
Lead sponsor
Medical University of Warsaw
NCT number
NCT06555237

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 40
  • From 1 Aug 2024 to the primary completion date, 1 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • contraindications to treatment with propranolol (drug hypersensitivity, atrioventricular block, severe bradycardia) disopyramide (drug hypersensitivity, WPW syndrome, atrioventricular block, QT prolongation) trametinib (drug hypersensitivity)

Other

  • lack of consent of the child's guardians to participate in the study

Who the study is looking for

  • patient with diagnosed RASopathy
  • patient with diagnosed hypertrophic cardiomyopathy
  • signed innform consent

Age in the registry: 1 day to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Paediatrics, The Medical University of Warsaw, Poland
Coordinator of this site? Confirm its status
WarsawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.